Sökning: WFRF:(Aandahl A) > (2015-2017) > Adverse events in a...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 06695naa a2201021 4500 | |
001 | oai:DiVA.org:umu-120207 | |
003 | SwePub | |
008 | 160511s2016 | |||||||||||000 ||eng| | |
009 | oai:lup.lub.lu.se:fbe5c160-409e-4caf-b214-8c34e5f23409 | |
009 | oai:DiVA.org:liu-135128 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1202072 URI |
024 | 7 | a https://doi.org/10.1016/j.transci.2016.01.0032 DOI |
024 | 7 | a https://lup.lub.lu.se/record/85774142 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1351282 URI |
040 | a (SwePub)umud (SwePub)lud (SwePub)liu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a for2 swepub-publicationtype |
100 | 1 | a Mörtzell Henriksson, Monicau Umeå universitet,Medicin,Nephrol, Umeå, Sweden4 aut0 (Swepub:umu)momo0019 |
245 | 1 0 | a Adverse events in apheresis :b an update of the WAA registry data |
264 | 1 | b Elsevier,c 2016 |
338 | a electronic2 rdacarrier | |
520 | a Apheresis with different procedures and devices are used for a variety of indications that may have different adverse events (AEs). The aim of this study was to clarify the extent and possible reasons of various side effects based on data from a multinational registry. The WAA-apheresis registry data focus on adverse events in a total of 50846 procedures in 7142 patients (42% women). AEs were graded as mild, moderate (need for medication), severe (interruption due to the AE) or death (due to AE). More AEs occurred during the first procedures versus subsequent (8.4 and 5.5%, respectively). AEs were mild in 2.4% (due to access 54%, device 7%, hypotension 15%, tingling 8%), moderate in 3% (tingling 58%, urticaria 15%, hypotension 10%, nausea 3%), and severe in 0.4% of procedures (syncope/hypotension 32%, urticaria 17%, chills/fever 8%, arrhythmia/asystole 4.5%, nausea/vomiting 4%). Hypotension was most common if albumin was used as the replacement fluid, and urticaria when plasma was used. Arrhythmia occurred to similar extents when using plasma or albumin as replacement. In 64% of procedures with bronchospasm, plasma was part of the replacement fluid used. Severe AEs are rare. Although most reactions are mild and moderate, several side effects may be critical for the patient. We present side effects in relation to the procedures and suggest that safety is increased by regular vital sign measurements, cardiac monitoring and by having emergency equipment nearby. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Urologi och njurmedicin0 (SwePub)302142 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Urology and Nephrology0 (SwePub)302142 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Hematologi0 (SwePub)302022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Hematology0 (SwePub)302022 hsv//eng |
653 | a Apheresis | |
653 | a Adverse events | |
653 | a Plasma | |
653 | a Albumin | |
653 | a Donor | |
653 | a Adverse events | |
653 | a Albumin | |
653 | a Apheresis | |
653 | a Donor | |
653 | a Plasma | |
700 | 1 | a Newman, Eu Bone Marrow Transplant and Apheresis, New South Wales, Australia4 aut |
700 | 1 | a Witt, Vu St. Anna, Vienna, Austria4 aut |
700 | 1 | a Derfler, Ku AKH, Vienna, Austria4 aut |
700 | 1 | a Leitner, Gu AKH, Vienna, Austria4 aut |
700 | 1 | a Eloot, Su Gent, Belgium4 aut |
700 | 1 | a Dhondt, Au Gent, Belgium4 aut |
700 | 1 | a Deeren, Du Roeselar, Belgium4 aut |
700 | 1 | a Rock, Gu Canada4 aut |
700 | 1 | a Ptak, Ju Frydek-Mistek, Czech Republic4 aut |
700 | 1 | a Blaha, Mu Hradec Kralove, Czech Republic4 aut |
700 | 1 | a Lanska, Mu Hradec Kralove, Czech Republic4 aut |
700 | 1 | a Gasova, Zu Prague, Czech Republic4 aut |
700 | 1 | a Hrdlickova, Ru Ostrava, Czech Republic4 aut |
700 | 1 | a Ramlow, Wu Rostock, Germany4 aut |
700 | 1 | a Prophet, Hu Rostock, Germany4 aut |
700 | 1 | a Liumbruno, Gu Livorno, Italy4 aut |
700 | 1 | a Mori, Eu Livorno, Italy4 aut |
700 | 1 | a Griskevicius, Au Vilnius, Lithuania,BC, Umeå, Sweden4 aut |
700 | 1 | a Audzijoniene, Ju Vilnius, Lithuania4 aut |
700 | 1 | a Vrielink, Hu Amsterdam, The Netherlands4 aut |
700 | 1 | a Rombout, Su Maastricht, The Netherlands4 aut |
700 | 1 | a Aandahl, Au Oslo, Norway,Skopje, Macedonia,Nephrol., Karlstad, Sweden4 aut |
700 | 1 | a Sikole, A4 aut |
700 | 1 | a Tomaz, Ju Coimbra, Portugal4 aut |
700 | 1 | a Lalic, Ku Belgrade, Serbia4 aut |
700 | 1 | a Mazic, Su Zagreb, Croatia4 aut |
700 | 1 | a Strineholm, Vu Orebro, Sweden4 aut |
700 | 1 | a Brink, Bu Huddinge, Sweden,Nephrol, Umeå, Sweden,Nephrol., Skövde, Sweden4 aut |
700 | 1 | a Berlin, Göstau Linköpings universitet,Avdelningen för neuro- och inflammationsvetenskap,Medicinska fakulteten,Region Östergötland, Klinisk immunologi och transfusionsmedicin4 aut0 (Swepub:liu)gosbe95 |
700 | 1 | a Dykes, Josefinau Lund University,Lunds universitet,Avdelningen för hematologi och transfusionsmedicin,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Hematology and Transfusion Medicine,Department of Laboratory Medicine,Faculty of Medicine,Lund, Sweden4 aut0 (Swepub:lu)efor-jdy |
700 | 1 | a Toss, Fu BC, Umeå, Sweden4 aut |
700 | 1 | a Axelsson, C G4 aut |
700 | 1 | a Stegmayr, Berndu Umeå universitet,Medicin4 aut0 (Swepub:umu)best0006 |
700 | 1 | a Nilsson, Tu Nephrol, Uppsala, Sweden4 aut |
700 | 1 | a Norda, Ru BC, Uppsala, Sweden4 aut |
700 | 1 | a Knutson, Fu BC, Uppsala, Sweden4 aut |
700 | 1 | a Ramsauer, Berndu Skövde4 aut0 (Swepub:umu)bera0016 |
700 | 1 | a Wahlström, A4 aut |
710 | 2 | a Umeå universitetb Medicin4 org |
773 | 0 | t Transfusion and apheresis scienced : Elsevierg 54:1, s. 2-15q 54:1<2-15x 1473-0502x 1878-1683 |
856 | 4 | u https://doi.org/10.1016/j.transci.2016.01.003y Fulltext |
856 | 4 | u https://umu.diva-portal.org/smash/get/diva2:927154/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u http://www.trasci.com/article/S1473050216000057/pdf |
856 | 4 | u http://www.ncbi.nlm.nih.gov/pubmed/26776481?dopt=Abstractx freey FULLTEXT |
856 | 4 | u http://dx.doi.org/10.1016/j.transci.2016.01.003x freey FULLTEXT |
856 | 4 | u https://liu.diva-portal.org/smash/get/diva2:1079874/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-120207 |
856 | 4 8 | u https://doi.org/10.1016/j.transci.2016.01.003 |
856 | 4 8 | u https://lup.lub.lu.se/record/8577414 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-135128 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.